Couzin, Jennifer <br/><br/>
Drug safety. Heart attack risk overshadows a popular diabetes therapy.  [electronic resource] 

 -  Science (New York, N.Y.)  Jun 2007 
 - 1550-1 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.316.5831.1550  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Clinical Trials as Topic<br/>Diabetes Mellitus--drug therapy<br/>Drug Industry<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Meta-Analysis as Topic<br/>Myocardial Infarction--chemically induced<br/>Risk<br/>Risk Factors<br/>Rosiglitazone<br/>Thiazolidinediones--adverse effects<br/>Triglycerides--blood